<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04755179</url>
  </required_header>
  <id_info>
    <org_study_id>W18_302#18.348</org_study_id>
    <nct_id>NCT04755179</nct_id>
  </id_info>
  <brief_title>Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population</brief_title>
  <acronym>CAPP</acronym>
  <official_title>The Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramon Gorter</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to evaluate the effect of different treatment strategies on overall&#xD;
      complications, health related-Quality of Life (hr-QOL) and costs among two subtypes of&#xD;
      complex appendicitis in children (&lt;18 years old).&#xD;
&#xD;
      Main research questions: What is the difference in overall complications at three months&#xD;
      between:&#xD;
&#xD;
      Subgroup 1 (complex appendicitis without abscess/mass formation): Laparoscopic (LA) and open&#xD;
      appendectomy (OA) Subgroup 2: (complex appendicitis with abscess/mass formation):&#xD;
      Non-operative treatment (NOT) and direct appendectomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up till now initiated research projects worldwide mainly focus on simple appendicitis&#xD;
      (questioning the necessity of an appendectomy). However, complex appendicitis is associated&#xD;
      with significant morbidity (up to 30%), prolonged hospital stay and high costs.&#xD;
      Identification of the optimal treatment strategy for children with complex appendicitis is&#xD;
      therefore essential. Heterogeneity in the treatment of complex appendicitis still exists in&#xD;
      daily practice and reflects the lack of high-quality data and emphasizes the need for&#xD;
      well-designed studies. Complex appendicitis can be divided into two subtypes:&#xD;
&#xD;
        1. Complex appendicitis without mass/abscess. (subgroup 1) Although (inter)national&#xD;
           guidelines agree that appendectomy should be usual care, the optimal approach (open or&#xD;
           laparoscopy) is unclear. Laparoscopic appendectomy (LA) is increasingly applied both in&#xD;
           adults (80%) and children (60%). Benefits reported for LA in children are, but not&#xD;
           limited to, less superficial site infection (SSI), reduced length of hospital stay and&#xD;
           significant less postoperative bowel obstruction compared with open appendectomy (OA).&#xD;
           Reluctance for usage of LA in this specific subgroup, however, remains due to the&#xD;
           potential higher incidence of post-appendectomy abscess formation (PAA) reported.&#xD;
           However, the quality of studies on this topic is low and there is considerable&#xD;
           inconsistency in results.&#xD;
&#xD;
        2. Complex appendicitis with mass/abscess. (subgroup 2) The recommendation made in our&#xD;
           national guideline (to perform direct appendectomy in this subgroup) is not in line with&#xD;
           the available literature. A recent Cochrane review on this topic could only include two&#xD;
           trials and stated that no firm conclusions could be drawn. An older systematic review,&#xD;
           including 7 studies in children, concluded that non-operative treatment (NOT) led to&#xD;
           fewer complications, specifically SSI and PAA, when compared to direct appendectomy.&#xD;
           Still the recommendation from our national guideline is to perform a direct appendectomy&#xD;
           based upon good experiences in the pediatric academic centers.&#xD;
&#xD;
      In order to investigate the optimal treatment for children with complex appendicitis we will&#xD;
      perform a nationwide, multi-center, comparative, prospective cohort study. For the purpose of&#xD;
      this study, treatment strategies will be standardized among the participating hospitals in&#xD;
      order to reduce heterogeneity. Prospectively derived, high quality data will be sufficient to&#xD;
      answer the research questions regarding the optimal treatment strategy for each subtype of&#xD;
      complex appendicitis in the pediatric population. As it is a non-randomized prospective&#xD;
      cohort study, propensity score matching technique will be performed in order to estimate the&#xD;
      effect of the treatments adjusted for potential confounders.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">August 12, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 12, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall complications</measure>
    <time_frame>3 months</time_frame>
    <description>The proportion of patients experiencing any complication within 3 months after inclusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postappendectomy abscess</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion patients with a postappendectomy abscess</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Superficial Site Infection</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of patients with a superficial site infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary bowel obstruction</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of patients with a secondary/prolonged bowel obstruction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days absent from school, social or sports events</measure>
    <time_frame>30 days, 3 months</time_frame>
    <description>Number of days absent from school, social or sports events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days absent from work</measure>
    <time_frame>30 days, 3 months</time_frame>
    <description>Number of days that parents are absent from work</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of extra visits</measure>
    <time_frame>30 days, 3 months</time_frame>
    <description>Total number of extra visits to the outpatient clinic, general pratctitioner's office or emergency department</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>3 months</time_frame>
    <description>Total length of hospital stay during follow-up due to trategy related treatment or complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of pain</measure>
    <time_frame>at inclusion/baseline (=day 0), 3 days, 5 days, 30 days, 3 months</time_frame>
    <description>Level of pain measured according to the Visual Analogue Scale (0-10 points, higher scores indicating worse outcomes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain medication utilization</measure>
    <time_frame>30 days, 3 months</time_frame>
    <description>Pain medication utilization during admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for appendectomy</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of patients not having to undergo appendectomy within 3 months after start of non-operative treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent appendicitis</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of patients experiencing recurrent appendicitis within 3 months after inclusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early failure of non-operative treatment</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of patients experiencing early failure of initial non-operative treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life questionnaire (EQ-5d-Youth/EQ-5d-Proxy)</measure>
    <time_frame>at inclusion/baseline (=day 0), 30 days, 3 months</time_frame>
    <description>QoL measured by the validated EQ-5d-Youth / EQ-5d-Proxy questionnaire (0-1 point, higher scores indicating better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life questionnaire (PedsQL 4.0)</measure>
    <time_frame>at inclusion/baseline (=day 0), 30 days, 3 months</time_frame>
    <description>QoL measured by the validated Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) (0-100 points, higher scores indicating better outcome) Labor Questionnaire (HLQ), Medical Consumption Questionnaire (iMCQ) and Productivity Consumption Questionnaire (iPCQ) and gathered actual health care cost</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical costs (iMCQ)</measure>
    <time_frame>at inclusion/baseline (=day 0), 30 days, 3 months</time_frame>
    <description>Medical costs measured by the iMedical Consumption Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-medical / indirect costs (iPCQ)</measure>
    <time_frame>at inclusion/baseline (=day 0), 30 days, 3 months</time_frame>
    <description>Non-medical / indirect costs measured by the iProductivity Cost Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality adjusted life months (QALM's)</measure>
    <time_frame>3 months</time_frame>
    <description>Quality adjusted life months calculated using outcomes 14 -17</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction questionnaire (PSQ-18)</measure>
    <time_frame>3 months</time_frame>
    <description>Patient satisfaction measured by the Patient Satisfaction Questionnaire (PSQ) (0-100, higher scores indicating better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction questionnaire (Net promotor score)</measure>
    <time_frame>3 months</time_frame>
    <description>Patient satisfaction measured by the NET PROMOTOR SCORE (0-10, higher scores indicating better outcome)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1308</enrollment>
  <condition>Appendicitis</condition>
  <condition>Appendix Mass</condition>
  <condition>Appendicitis Perforated</condition>
  <arm_group>
    <arm_group_label>Complex appendicitis without abscess or mass formation</arm_group_label>
    <description>All children (&lt;18 years old) that present with a suspicion of complex appendicitis without clinical or radiological signs of abscess or mass formation. Preoperative suspicion of complex appendicitis is based upon a previously developed clinical scoring system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Complex appendicitis with abscess or mass formation</arm_group_label>
    <description>All children (&lt;18 years old) that present with a suspicion of complex appendicitis with clinical or radiological signs of abscess or mass formation. Preoperative suspicion of complex appendicitis is based upon a previously developed clinical scoring system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic appendectomy</intervention_name>
    <description>Laparoscopic appendectomy is performed according to daily practice but with the following standardized key points:&#xD;
Conventional laparoscopy (three-trocar technique)&#xD;
In case of purulent fluid: Suction and no peritoneal lavage procedure&#xD;
Skelletizing of the mesoappendix (coagulation/clips according to routine practice locally)&#xD;
Appendiceal stump closure: with two endoloops and dissected between the endoloops. In case of involvement of the appendiceal base, the use of endostapler is recommended.&#xD;
Withdrawal of appendix: principle of abdominal wall protection is followed (trocar technique / endobag)&#xD;
No drain placement, no nasogastric tube, and no urinary catheter routinely, only on indication.&#xD;
Closure of wounds as appropriate</description>
    <arm_group_label>Complex appendicitis without abscess or mass formation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open appendectomy</intervention_name>
    <description>Open appendectomy will be performed according to the following standardized key points:&#xD;
Gridiron incision at the right lower quadrant. (McBurney's point)&#xD;
After obtaining access to the abdominal cavity the principle of abdominal wall protection will be followed.&#xD;
The appendiceal stump will be closed by ligation, not a purse string suture.&#xD;
Closure of wounds as appropriate</description>
    <arm_group_label>Complex appendicitis without abscess or mass formation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-operative treatment</intervention_name>
    <description>Non-operative treatment consisting of administration of intravenous antibiotics with or without drainage procedures (in case of an abscess), reserving an appendectomy for those not responding or with recurrent disease.&#xD;
One of the two antibiotic regiments:&#xD;
Combination A:&#xD;
Amoxicillin/clavulanic acid 25/2.5mg/kg 6 hourly (total 100/10 mg/kg daily. Maximum 6000/600mg a day) for children &lt;40 kg OR Amoxicillin/clavulanic acid 1000/200mg/kg 8 hourly (total 3000/6000 mg/kg daily) for children &gt; 40 kg&#xD;
Gentamicin 7mg/kg once daily&#xD;
Combination B:&#xD;
Cefuroxim 25 mg/kg 6 hourly (total 100 mg/kg/day. Maximum 6gram/day)&#xD;
Metronidazole 10mg/kg 8hourly (total 30 mg/kg/day. Maximum 4000 mg/day) In case of peri-appendicular abscess the decision can be made to perform a drainage procedure either percutaneously or surgical.</description>
    <arm_group_label>Complex appendicitis with abscess or mass formation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Direct appendectomy</intervention_name>
    <description>laparoscopic or open appendectomy as described</description>
    <arm_group_label>Complex appendicitis with abscess or mass formation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All children that present with a preoperative suspicion of complex appendicitis. This&#xD;
        suspicion is based on 4 points or more on the abovementioned complex appendicitis scoring&#xD;
        system OR a high index of suspicion of complex appendicitis by the treating physician.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Eligible for inclusion are all children &lt;18 years old that need to undergo treatment for&#xD;
        the suspicion of complex appendicitis. Suspicion of complex appendicitis is based upon the&#xD;
        following predefined criteria:&#xD;
&#xD;
        4 or more points on our scoring system developed to predict complex appendicitis. The&#xD;
        diagnostic accuracy of this scoring system is 91% (Range: 84-98%). This scoring system&#xD;
        consists of five variables (clinical, biochemical and radiological,each awarded points). In&#xD;
        case the total score is 4 or more points, the patient is likely to have complex&#xD;
        appendicitis. Variables included in the scoring system are:&#xD;
&#xD;
          -  Diffuse abdominal guarding (3 points)&#xD;
&#xD;
          -  CRP level more than 38 mg/L (2 points)&#xD;
&#xD;
          -  Signs on ultrasound / imaging indicative for complex appendicitis (2 points)&#xD;
&#xD;
          -  More than one day abdominal pain (2 points)&#xD;
&#xD;
          -  Temperature more than 37.5 degrees Celsius (1 point)&#xD;
&#xD;
        Or&#xD;
&#xD;
        High index of suspicion of complex appendicitis by the treating physician. If this is the&#xD;
        case, the treating physician will make pre-treatment note upon what clinical, biochemical&#xD;
        or radiological variable the high index of suspicion is based.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adult patients (=18 years old)&#xD;
&#xD;
          -  Children with a suspicion of simple appendicitis (based upon the previous mentioned&#xD;
             scoring system and radiological features)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ramon Gorter, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amsterdam UMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ramon Gorter, MD PhD</last_name>
    <phone>0031-205665693</phone>
    <email>rr.gorter@amsterdamumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul van Amstel, MD</last_name>
    <phone>0031-205665693</phone>
    <email>p.vanamstel@amsterdamumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwest hospital group</name>
      <address>
        <city>Alkmaar</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taco Bijlsma, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flevoziekenhuis</name>
      <address>
        <city>Almere</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gwen Diepenhorst, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meander MC</name>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esther Consten, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Amstelland</name>
      <address>
        <city>Amstelveen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Garssen, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC - Location AMC</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramon Gorter, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC - Location VUmc</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramon Gorter, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OLVG</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Leijdekkers, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gelre hospital</name>
      <address>
        <city>Apeldoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugo Bolhuis, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rijnstate</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charlotte Blanken, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bravis Hospital</name>
      <address>
        <city>Bergen Op Zoom</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Floortje van Eijck, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Red Cross Hospital</name>
      <address>
        <city>Beverwijk</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annebeth de Vries, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tergooi</name>
      <address>
        <city>Blaricum</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nanette van Geloven, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amphia</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter Boele van Hensbroek, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IJsselland Hospital</name>
      <address>
        <city>Capelle Aan Den IJssel</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Groenendijk, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haga/JKZ</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerda Zijp, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzer Hospital</name>
      <address>
        <city>Dordrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maarten Lijkwan, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catharina hospital</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Misha Luyer, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Admiraal de Ruyter Hospital</name>
      <address>
        <city>Goes</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan Jansen, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMCG</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Hulscher, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spaarne Gasthuis</name>
      <address>
        <city>Haarlem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Oosterling, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zuyderland MC</name>
      <address>
        <city>Heerlen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evert-Jan Boerma, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dijklander</name>
      <address>
        <city>Hoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise de Widt, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sint Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Go, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radboud UMC</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivo de Blaauw, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laurentius</name>
      <address>
        <city>Roermond</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeroen Leijtens, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Keyzer, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Franciscus Gasthuis &amp; Vlietland</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marijn Poelman, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ikazia</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wouter Vles, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maasstad Hospital</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles van Rossem, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maxima Medical Centre</name>
      <address>
        <city>Veldhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mart Bender, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zaans Medical Centre</name>
      <address>
        <city>Zaandam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frank den Boer, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Isala</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Nieuwenhuijs, MD PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 29, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2021</study_first_posted>
  <last_update_submitted>February 10, 2021</last_update_submitted>
  <last_update_submitted_qc>February 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Ramon Gorter</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Complex appendicitis</keyword>
  <keyword>Children</keyword>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

